Ubs Group Ag Cryo Cell International Inc Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Cryo Cell International Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,496 shares of CCEL stock, worth $7,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,496
Previous 3,148
52.48%
Holding current value
$7,480
Previous $23,000
60.87%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CCEL
# of Institutions
22Shares Held
1MCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$2.05 Million1.73% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$826,5000.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA118KShares$591,1750.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$555,1750.02% of portfolio
-
Geode Capital Management, LLC Boston, MA45.2KShares$226,1500.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $42.6M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...